Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial? RĂ¼diger von KriesMonika HermannRalf Reinert Original Paper Pages: S140 - S143
Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution Willam P. Hausdorff Original Paper Pages: S135 - S139
Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California Steven BlackHenry Shinefield Original Paper Pages: S127 - S131
Time to recommend pneumococcal vaccination for all children in Europe: experience in France Mark A. FletcherRobert TetelboumBernard Fritzell Original Paper Pages: S132 - S134
Introduction of pneumococcal vaccine to standard immunisation programmes in Europe: what are we waiting for? Ulrich Heininger Original Paper Pages: S125 - S126